The Danish National Multiple Myeloma Registry

Autor: Gimsing P, Holmström MO, Klausen TW, Andersen NF, Gregersen H, Pedersen RS, Plesner T, Pedersen PT, Frederiksen M, Frølund U, Helleberg C, Vangsted A, de Nully Brown P, Abildgaard N

Publikováno v: Clinical Epidemiology, Vol Volume 8, Pp 583-587 (2016)

Peter Gimsing,1 Morten O Holmström,2 Tobias Wirenfelt Klausen,3 Niels Frost Andersen,4 Henrik Gregersen,5 Robert Schou Pedersen,6 Torben Plesner,7 Per Trøllund Pedersen,8 Mikael Frederiksen,9 Ulf Frølund,2 Carsten Helleberg,3 Annette Vangsted,1 Pe

Externí odkaz: https://doaj.org/article/b1595f374813485dacfe63b1e1f1f473

Oral ixazomib maintenance following autologous stem cell transplantation (TOURMALINE-MM3): a double-blind, randomised, placebo-controlled phase 3 trial

Autor: Dimopoulos, M.A. Gay, F. Schjesvold, F. Beksac, M. Hajek, R. Weisel, K.C. Goldschmidt, H. Maisnar, V. Moreau, P. Min, C.K. Pluta, A. Chng, W.-J. Kaiser, M. Zweegman, S. Mateos, M.-V. Spencer, A. Iida, S. Morgan, G. Suryanarayan, K. Teng, Z. Skacel, T. Palumbo, A. Dash, A.B. Gupta, N. Labotka, R. Rajkumar, S.V. Bar, D. Basso, A. Fantl, D. He, S. Horvath, N. Lee, C. Rowlings, P. Taylor, K. Cochrane, T. Kwok, F. Ramanathan, S. Agis, H. Zojer, N. Kentos, A. Offner, F. Van Droogenbroeck, J. Wu, K.L. Maiolino, A. Martinez, G. Zanella, K. Capra, M. Araújo, S. Gregora, E. Pour, L. Scudla, V. Spicka, I. Abildgaard, N. Andersen, N. Jensen, B.A. Helleberg, C. Plesner, T. Salomo, M. Svirskaite, A. Delarue, R. Blau, I. Schieferdecker, A. Teleanu, V. Munder, M. Röllig, C. Salwender, H.-J. Fuhrmann, S. Weisel, K. Duerig, J. Zeis, M. Klein, S. Reimer, P. Schmidt, C. Scheid, C. Mayer, K. Hoffmann, M. Sosada, M. Dimopoulos, A. Delimpasi, S. Kyrtsonis, M.-C. Anagnostopoulos, A. Nagy, Z. Illés, Á. Egyed, M. Borbényi, Z. Mikala, G. Dally, N. Horowitz, N. Gutwein, O. Nemets, A. Vaxman, I. Shvetz, O. Trestman, S. Ruchlemer, R. Nagler, A. Tadmor, T. Rouvio, O. Preis, M. Cavo, M. De Rosa, L. Musto, P. Cafro, A. Tosi, P. Offidani, M. Corso, A. Rossi, G. Liberati, A.M. Bosi, A. Suzuki, K. Nakaseko, C. Ishikawa, T. Matsumoto, M. Nagai, H. Sunami, K. Chou, T. Akashi, K. Takezako, N. Hagiwara, S. Eom, H.S. Jo, D.-Y. Kim, J.S. Lee, J.H. Yoon, S.S. Yoon, D.H. Kim, K. Levin, M.-D. Vellenga, E. Minnema, M. Waage, A. Haukås, E. Grosicki, S. Pluta, A. Robak, T. Marques, H. Bergantim, R. Campilho, F. Chng, W.J. Goh, Y.T. McDonald, A. Rapoport, B. Álvarez Rivas, M.A. De Arriba de La Fuente, F. González Montes, Y. Martin Sanchez, J. Mateos, M.V. Oriol Rocafiguera, A. Rosinol, L. San Miguel, J. Pérez de Oteyza, J. Encinas, C. Alegre-Amor, A. López-Guía, A. Axelsson, P. Carlson, K. Stromberg, O. Hansson, M. Hveding Blimark, C. Mueller, R. Chen, C.-C. Liu, T.-C. Huang, S.-Y. Wang, P.-N. Na Nakorn, T. Prayongratana, K. Unal, A. Goker, H. Sonmez, M. Korenkova, S. Chaidos, A. Oakervee, H. Sati, H. Benjamin, R. Wechalekar, A. Garg, M. Ramasamy, K. Cook, G. Chantry, A. Jenner, M. Buadi, F. Berryman, R. Janakiram, M. TOURMALINE-MM3 study group

Background: Maintenance therapy following autologous stem cell transplantation (ASCT) can delay disease progression and prolong survival in patients with multiple myeloma. Ixazomib is ideally suited for maintenance therapy given its convenient once-w

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______2127::7a2acf7f9477bb9d6fa6364f70564f15
https://pergamos.lib.uoa.gr/uoa/dl/object/uoadl:3106326

Smouldering multiple myeloma risk factors for progression. An analysis of 289 cases in the danish multiple myeloma registry

Autor: Sørring, R, Klausen, T W, Frølund, U C, Gregersen, Henrik, Helleberg, C, Kristensen, D L, Andersen, N F, Plesner, T., Pulczynski, S., Abildgaard, Niels, Mourits-Andersen, Torben, Clausen, N T, Vangsted, A, Salomo, M, Gimsing, P

Publikováno v: Sørrig, R, Klausen, T W, Frølund, U C, Gregersen, H, Helleberg, C, L. Kristensen, D, Andersen, N F, Plesner, T, Pulczinsky, S, Albildgaard, N, Mourits-Andersen, T, Clausen, N T, Vangsted, A, Salomo, M & Gimsing, P 2015, ' Smouldering multiple myeloma risk factors for progression. An analysis of 289 cases in the danish multiple myeloma registry ', Annual Congress of the European Hematology Association, Milano, Italy, 12/06/2014-15/06/2014 .
Sørring, R, Klausen, T W, Frølund, U C, Gregersen, H, Helleberg, C, Kristensen, D L, Andersen, N F, Plesner, T, Pulczynski, S, Abildgaard, N, Mourits-Andersen, T, Clausen, N T, Vangsted, A, Salomo, M & Gimsing, P 2014, ' Smouldering Multiple Myeloma Risk Factors for Progression an Analysis og 289 Cases in The Danish Multiple Myeloma Registry ', Haematologica, vol. 99, no. Supplement 1, P977, pp. 370 . < http://www.haematologica.it/content/99/supplement_1/1.full.pdf+html >

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::7cf7b4b76e581bda25e728412ee7ffa4
https://portal.findresearcher.sdu.dk/da/publications/0a417ff1-fe8c-4a35-a2d6-78aa6fc1461e

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.